EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effect of safranal or candesartan on 3-nitropropionicacid-induced biochemical, behavioral and histological alterations in a rat model of Huntington’s disease

Nagwa Ibrahim Shehata, Dina Mohamed Abd El-Salam, Roqaya Mahmoud Hussein, Sherine Maher Rizk iD

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0293660 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Nagwa Ibrahim Shehata und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, Biochemistry Department, Cairo University, Cairo, Egypt. Hauptthemen laut MEDLINE: Huntington Disease, Neuroprotective Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

3-nitropropionic acid (3-NP) is a potent mitochondrial inhibitor mycotoxin. Systemic administration of 3-NP can induce Huntington’s disease (HD)-like symptoms in experimental animals. Safranal (Safr) that is found in saffron essential oil has antioxidant, anti-inflammatory and anti-apoptotic actions. Candesartan (Cands) is an angiotensin receptor blocker that has the potential to prevent cognitive deficits. The present study aims to investigate the potential neuroprotective efficacy of Safr or Cands in 3-NP-induced rat model of HD. The experiments continued for nine consecutive days. Rats were randomly assigned into seven groups. The first group (Safr-control) was daily intraperitoneally injected with paraffin oil. The second group (Cands- and 3-NP-control) daily received an oral dose of 0.5% carboxymethylcellulose followed by an intraperitoneal injection of 0.9% saline. The third and fourth groups received a single daily dose of 50 mg/kg Safr (intraperitoneal) and 1 mg/kg Cands (oral), respectively. The sixth group was daily treated with 50 mg Safr kg/day (intraperitoneal) and was intraperitoneally injected with 20 mg 3-NP/ kg, from the 3 rd till the 9 th day. The seventh group was daily treated with 1 mg Cands /kg/day (oral) and was intraperitoneally injected with 20 mg 3-NP/ kg, from the 3 rd till the 9 th day. The present results revealed that 3-NP injection induced a considerable body weight loss, impaired memory and locomotor activity, reduced striatal monoamine levels. Furthermore, 3-NP administration remarkably increased striatal malondialdehyde and nitric oxide levels, whereas markedly decreased the total antioxidant capacity. Moreover, 3-NP significantly upregulated the activities of inducible nitric oxide synthase and caspase-3 as well as the Fas ligand, in striatum. On the contrary, Safr and Cands remarkably alleviated the above-mentioned 3-NP-induced alterations. In conclusion, Safr and Cands may prevent or delay the progression of HD and its associated impairments through their antioxidant, anti-inflammatory, anti-apoptotic and neuromodulator effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Huntington DiseaseNeuroprotective AgentsRatsAnimalsAntioxidantsRats, WistarMotor ActivityCorpus StriatumAnti-Inflammatory AgentsNitro CompoundsPropionatesDisease Models, AnimalTerpenesCyclohexenesBenzimidazolesBiphenyl CompoundsTetrazoles

Substanzen

AntioxidantsAnti-Inflammatory AgentsNitro CompoundsPropionatesNeuroprotective AgentssafranalTerpenesCyclohexenescandesartanBenzimidazoles

Autor:innen und Institutionen

  • Faculty of Pharmacy, Biochemistry Department, Cairo University, Cairo, Egypt.
  • Hazards Department, Egyptian Drug Authority (EDA), Cairo, Egypt.

ORCID-Profile: Sherine Maher Rizk

Zitieren

APA

Shehata, N. I., Abd El-Salam, D. M., Hussein, R. M., & Rizk, S. M. (2023). Effect of safranal or candesartan on 3-nitropropionicacid-induced biochemical, behavioral and histological alterations in a rat model of Huntington’s disease. PLOS ONE. https://doi.org/10.1371/journal.pone.0293660

Vancouver

Shehata NI, Abd El-Salam DM, Hussein RM, Rizk SM. Effect of safranal or candesartan on 3-nitropropionicacid-induced biochemical, behavioral and histological alterations in a rat model of Huntington’s disease. PLOS ONE. 2023. doi:10.1371/journal.pone.0293660

BibTeX
@article{Shehata2023,
  author = {Shehata, Nagwa Ibrahim and Abd El-Salam, Dina Mohamed and Hussein, Roqaya Mahmoud and Rizk, Sherine Maher},
  title = {Effect of safranal or candesartan on 3-nitropropionicacid-induced biochemical, behavioral and histological alterations in a rat model of Huntington’s disease},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0293660}
}
Kostenlos starten →